CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.66B, above the global median of $1.18B
- FinancialsAltman Z-Score 3.97: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.42%Above 5Y avg (1.70%)
Annual Rate
CNY 0.15Paid annual
Payout Ratio
74.3%Moderate
Payback Period
28.7 yr
Last Ex-Dividend
Jun 24, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
11.12BCNY1.66B · vs all stocks (USD)
Trailing P/E
21.30xRevenue (TTM)
6.82BCNY1.02B · vs all stocks (USD)
Profit Margin
7.31%Beta
0.2070xvs all stocks
52-Week Change
0.46%vs all stocks
Market Capitalization
11.12BCNY1.66B · vs all stocks (USD)
Enterprise Value
10.14BCNY1.51B · vs all stocks (USD)
Trailing P/E
21.30xForward P/E
13.31xPrice to Sales (TTM)
1.59xPrice to Book (MRQ)
1.53xEnterprise to Revenue
1.49xEnterprise to EBITDA
10.12xGross Margin
56.86%Profit Margin
7.31%Operating Margin
12.92%Return on Assets (TTM)
4.21%Return on Equity (TTM)
7.36%Revenue (TTM)
6.82BCNY1.02B · vs all stocks (USD)
Revenue per Share (TTM)
2.75CNYUpdated Sep 21, 2026Quarterly Revenue Growth
7.30%Gross Profit (TTM)
3.72BCNY555.20M · vs all stocks (USD)
EBITDA (TTM)
845.69MCNY126.29M · vs all stocks (USD)
Net Income (TTM)
498.53MCNY74.44M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
9.20%Operating Cash Flow (TTM)
1.08BCNY161.74M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
454.32MCNY67.84M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1500CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
3.42%vs all stocks
5-Year Average Dividend Yield
1.70%vs all stocks
Payout Ratio
74.26%Minority Interest (Equity)
105.11MCNYFY2025 · Dec 31, 2025Revenue
6.47BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
3.02BCNYFY2025 · Dec 31, 2025Gross Profit
3.45BCNYFY2025 · Dec 31, 2025Operating Income
624.18MCNY93.21M · vs all stocks (USD)
Pre-tax Income
645.17MCNYFY2025 · Dec 31, 2025Income Tax Expense
153.62MCNYFY2025 · Dec 31, 2025Net Income
491.55MCNYFY2025 · Dec 31, 2025EBIT
652.96MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.03BCNYFY2025 · Dec 31, 2025Research & Development
262.22MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
1.55BCNYFY2025 · Dec 31, 2025Other Operating Expenses
87.66MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
17.47MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
7.79MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1900CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1900CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
2.50BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
2.50BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
491.55MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-17.19MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
671.57MCNYFY2025 · Dec 31, 2025Free Cash Flow
549.84MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.60BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
491.55MCNYFY2025 · Dec 31, 2025Other Non-cash Items
7.59MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
156.52MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
15.90MCNYFY2025 · Dec 31, 2025Capital Expenditures
-121.73MCNYFY2025 · Dec 31, 2025Sale of Investments
55.90MCNYFY2025 · Dec 31, 2025Other Investing Activity
1.29MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-64.54MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
282.03MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-403.99MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-383.64MCNYFY2025 · Dec 31, 2025Other Financing Charges
18.58MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-487.01MCNYFY2025 · Dec 31, 2025Shares Outstanding
2.54BSharesUpdated Sep 21, 2026Float Shares
1.64BSharesUpdated Sep 21, 2026% Held by Insiders
36.26%vs all stocks
% Held by Institutions
4.95%vs all stocks
Total Cash (MRQ)
904.56MCNY135.08M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.3560CNYUpdated Sep 21, 2026Total Debt (MRQ)
113.45MCNY16.94M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0158xCurrent Ratio (MRQ)
1.88xBook Value per Share (MRQ)
2.78CNYUpdated Sep 21, 2026Total Assets
9.98BCNY1.49B · vs all stocks (USD)
Total Current Assets
4.56BCNYFY2025 · Dec 31, 2025Total Liabilities
2.83BCNYFY2025 · Dec 31, 2025Total Non-current Assets
5.43BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
393.78MCNYFY2025 · Dec 31, 2025Total Current Liabilities
2.44BCNYFY2025 · Dec 31, 2025Cash
1.65BCNYFY2025 · Dec 31, 2025Cash Equivalents
21.10MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.67BCNYFY2025 · Dec 31, 2025Accounts Receivable
990.92MCNYFY2025 · Dec 31, 2025Inventory
1.23BCNYFY2025 · Dec 31, 2025Accounts Payable
955.57MCNYFY2025 · Dec 31, 2025Short-term Debt
262.72MCNYFY2025 · Dec 31, 2025Other Current Liabilities
4.10MCNYFY2025 · Dec 31, 2025Long-term Debt
40.99MCNYFY2025 · Dec 31, 2025Common Stock (Book)
2.53BCNYFY2025 · Dec 31, 2025Retained Earnings
3.53BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
7.15BCNY1.07B · vs all stocks (USD)
52-Week Low
3.77CNYUpdated Sep 21, 202652-Week High
5.17CNYUpdated Sep 21, 202652-Week Change
0.46%vs all stocks
Beta
0.2070xvs all stocks
50-Day MA
4.38CNYUpdated Sep 21, 2026200-Day MA
4.38CNYUpdated Sep 21, 2026Avg 10-Day Volume
38.12MSharesUpdated Sep 21, 2026Avg 30-Day Volume
84.49MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.2000CNYUpdated Sep 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.57Profit Margin: 0.07
Financial Health
Altman Z-Score 3.97: safe zoneNotable
Altman Z-Score: 3.97
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.66B, above the global median of $1.18BNotable
Market cap (USD): 1,660,365,968.152Global Median: 1,180,223,658.953
Revenue is $1.02B, above the global median of $548.88MNotable
Revenue (USD): 1,017,886,111.759Global Median: 548,883,780.48
Levered free cash flow is $67.84M, above the global median of $18.73MNotable
Levered free cash flow (USD): 67,843,940.099Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Nolato AB
Tier 1ProductionApproval-Gated PipelineRule
Tibet Cheezheng Tibetan Medicine Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hugel Inc.
Tier 1ProductionApproval-Gated PipelineRule
Absci Corporation
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Eton Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hualan Biological Engineering Inc.
Tier 1ProductionApproval-Gated PipelineRule
Marksans Pharma Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Pharmablock Sciences Nanjing Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Intellia Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Shyndec Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Timee Inc.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Beijing Xiaocheng Technology Co. Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Edan Instruments Inc.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities